Virginia Foley

There’s a particular energy that surrounds a small, emerging biopharma company approaching its first drug launch. It’s a mix of excitement, fear, ambition, and sheer logistical overwhelm; equal parts moonshot and tightrope. For regulatory advertising and promotional consultants, this territory is familiar. It is exhilarating, messy, and incredibly high stakes. And it never fails to reveal the same truth: scientific brilliance does not automatically translate into commercial readiness. In...

We’re no longer talking to the same people — or in the same way Traditional pharma advertising and promotional strategies that once targeted healthcare professionals, consumers, and payers now require an additional focus: AI platforms. The life sciences and healthcare industries are undergoing a transformative phase with the rise of Generative AI (GenAI). These AI systems, which include Large Language Models (LLMs) like ChatGPT and Gemini, create new content based on their vast training...